Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2009 1
2011 1
2013 2
2015 1
2016 1
2018 1
2019 1
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Results by year
Filters applied: . Clear all
Page 1
Did you mean kohno yuji (44 results)?
[INITIAL EXPERIENCE OF THE ENZALUTAMIDE TREATMENT FOR CASTRATION-RESISTANT PROSTATE CANCER].
Igarashi A, Fukagai T, Morita M, Hayashi K, Koshikiya A, Ogawa Y, Fuji K, Naoe M, Morita J, Oshinomi K, Nakazato T, Ogawa Y, Matsui Y, Shimada M, Inoue K, Saito K, Ogawa Y, Matsumoto Y, Sasaki H, Ota M, Yamamoto K, Shimoyama H, Imamura Y, Yamagishi M, Tanifuji S, Ishihara M, Shichijyo T, Sato N, Omori K, Matsubara E. Igarashi A, et al. Among authors: fuji k. Nihon Hinyokika Gakkai Zasshi. 2016;107(3):155-161. doi: 10.5980/jpnjurol.107.155. Nihon Hinyokika Gakkai Zasshi. 2016. PMID: 28740046 Free article. Japanese.
Systematic review and two new cases of primary upper urinary tract neuroendocrine carcinomas.
Nakasato T, Hiramatsu A, Matsui Y, Unoki T, Shimoyama H, Oshinomi K, Morita J, Maeda Y, Naoe M, Fuji K, Ogura H, Homma M, Yamochi T, Takimoto M, Ogawa Y. Nakasato T, et al. Among authors: fuji k. Cancer Treat Res Commun. 2018;17:23-30. doi: 10.1016/j.ctarc.2018.10.003. Epub 2018 Oct 9. Cancer Treat Res Commun. 2018. PMID: 30326420 Free article.
Long-term outcome of phase I/II clinical trial of Ad-OC-TK/VAL gene therapy for hormone-refractory metastatic prostate cancer.
Shirakawa T, Terao S, Hinata N, Tanaka K, Takenaka A, Hara I, Sugimura K, Matsuo M, Hamada K, Fuji K, Okegawa T, Higashihara E, Gardner TA, Kao C, Chung LW, Kamidono S, Fujisawa M, Gotoh A. Shirakawa T, et al. Among authors: fuji k. Hum Gene Ther. 2007 Dec;18(12):1225-32. doi: 10.1089/hum.2007.074. Hum Gene Ther. 2007. PMID: 18021019 Clinical Trial.
[Changes in serum prostate specific antigen and testosterone levels after chlormadinone acetate treatment in patients with benign prostatic hyperplasia : a prospective multicenter clinical study].
Fujimoto K, Hirao Y, Ohashi Y, Shibata Y, Fuji K, Tsuji H, Shimizu N, Miyazawa K, Nagata M, Ohtani N, Furuya R, Boku E. Fujimoto K, et al. Among authors: fuji k. Hinyokika Kiyo. 2011 Apr;57(4):177-83. Hinyokika Kiyo. 2011. PMID: 21646847 Free article. Japanese.